1. [1] Boucher TJ, McMahon SB. Neurotrophic factors and neuropathic pain. Curr Opin Pharmacol 2001; 1: 66-72. [DOI:10.1016/S1471-4892(01)00010-8]

2. [2] Azhary H, Farooq MU, Bhanushali M, Majid A, Kassab MY. Peripheral neuropathy: differential diagnosis and management. Am Fam Physician 2010; 81: 887-892.

3. [3] Ji RR, Suter MR. p38 MAPK, microglial signaling, and neuropathic pain. Mol Pain 2007; 3: 33. [DOI:10.1186/1744-8069-3-33] [PMID] [PMCID]

4. [4] Mellon SH, Griffin LD. Neurosteroids: biochemistry and clinical significance. Trends Endocrin Met 2002; 13: 35-43. [DOI:10.1016/S1043-2760(01)00503-3]

5. [5] Melcangi R, Garcia-Segura L, Mensah-Nyagan A. Neuroactive steroids: state of the art and new perspectives. Cell Mol Life Sci 2008; 65: 777-797. [DOI:10.1007/s00018-007-7403-5] [PMID]

6. [6] Pathirathna S, Brimelow BC, Jagodic MM, Krishnan K, Jiang X, Zorumski CF, et al. New evidence that both T-type calcium channels and GABA A channels are responsible for the potent peripheral analgesic effects of 5α-reduced neuroactive steroids. Pain 2005; 114: 429-443. [DOI:10.1016/j.pain.2005.01.009] [PMID]

7. [7] Goudet C, Magnaghi V, Landry M, Nagy F, Gereau RW, Pin JP. Metabotropic receptors for glutamate and GABA in pain. Brain Res Rev 2009; 60: 43-56. [DOI:10.1016/j.brainresrev.2008.12.007] [PMID]

8. [8] Devor M. Neuropathic pain: what do we do with all these theories? Acta Anaesth Scand 2001; 45: 1121-1127. [DOI:10.1034/j.1399-6576.2001.450912.x] [PMID]

9. [9] Patte-Mensah C, Meyer L, Schaeffer V, Mensah-Nyagan AG. Selective regulation of 3α-hydroxysteroid oxido-reductase expression in dorsal root ganglion neurons: A possible mechanism to cope with peripheral nerve injury-induced chronic pain. Pain 2010; 150: 522-534. [DOI:10.1016/j.pain.2010.06.004] [PMID]

10. [10] De Nicola AF, Labombarda F, Gonzalez Deniselle MC, Gonzalez SL, Garay L, Meyer M, et al. Progesterone neuroprotection in traumatic CNS injury and motoneuron degeneration. Front Neuroendocrinol 2009; 30: 173-187. [DOI:10.1016/j.yfrne.2009.03.001] [PMID]

11. [11] Vina J, Sanchis-Gomar F, Martinez-Bello V, Gomez-Cabrera MC. Exercise acts as a drug; the pharmacological benefits of exercise. Br J Pharmacol 2012; 167: 1-12. [DOI:10.1111/j.1476-5381.2012.01970.x] [PMID] [PMCID]

12. [12] Hutchinson KJ, Gómez‐Pinilla F, Crowe MJ, Ying Z, Basso DM. Three exercise paradigms differentially improve sensory recovery after spinal cord contusion in rats. Brain 2004; 127: 1403-1414. [DOI:10.1093/brain/awh160] [PMID]

13. [13] Cotman CW, Berchtold NC, Christie LA. Exercise builds brain health: key roles of growth factor cascades and inflammation. Trends Neurosci 2007; 30: 464-472. [DOI:10.1016/j.tins.2007.06.011] [PMID]

14. [14] Hayes K, Sprague S, Guo M, Davis W, Friedman A, Kumar A, et al. Forced, not voluntary, exercise effectively induces neuroprotection in stroke. Acta Neuropathol 2008; 115: 289-296. [DOI:10.1007/s00401-008-0340-z] [PMID] [PMCID]

15. [15] Davranche K, McMorris T. Specific effects of acute moderate exercise on cognitive control. Brain Cogn 2009; 69: 565-570. [DOI:10.1016/j.bandc.2008.12.001] [PMID]

16. [16] Greenwood BN, Fleshner M. Exercise, learned helplessness, and the stress-resistant brain. Neuromol Med 2008; 10: 81-98. [DOI:10.1007/s12017-008-8029-y] [PMID]

17. [17] Koltyn KF, Brellenthin AG, Cook DB, Sehgal N, Hillard C. Mechanisms of exercise-induced hypoalgesia. J Pain 2014; 15: 1294-1304. https://doi.org/10.1016/j.jpain.2014.01.412 [DOI:10.1016/j.jpain.2014.09.006] [PMID] [PMCID]

18. [18] Wright A, Sluka KA. Nonpharmacological treatments for musculoskeletal pain. Clin J Pain 2001; 17: 33-46. [DOI:10.1097/00002508-200103000-00006] [PMID]

19. [19] Dannecker EA, Koltyn KF. Pain during and within hours after exercise in healthy adults. Sports Med 2014; 44: 921-942. [DOI:10.1007/s40279-014-0172-z] [PMID]

20. [20] Sarkaki A, Saadipour K, Badavi M, Alaei H, Rahim F. Effects of forced treadmill exercise on pain threshold in morphine-addicted rats. J Clin Diagn Res 2007; 1: 555-560.

21. [21] Bennett GJ, Xie YK. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 1988; 33: 87-107. [DOI:10.1016/0304-3959(88)90209-6]

22. [22] Safakhah HA, Kor NM, Bazargani A, Bandegi AR, Pourbadie HG, Khoshkholgh-Sima B, Ghanbari A. Forced exercise attenuates neuropathic pain in chronic constriction injury of male rat: an investigation of oxidative stress and inflammation. J Pain Res 2017; 10: 1457. [DOI:10.2147/JPR.S135081] [PMID] [PMCID]

23. [23] Stagg NJ, Mata HP, Ibrahim MM, Henriksen EJ, Porreca F, Vanderah TW, Malan Jr TP. Regular exercise reverses sensory hypersensitivity in a rat neuropathic pain model: role of endogenous opioids. Anesthesiology 2011; 114: 940-948. [DOI:10.1097/ALN.0b013e318210f880] [PMID] [PMCID]

24. [24] González-Orozco JC, Camacho-Arroyo I. Progesterone actions during central nervous system development. Front Neurosci 2019; 13: 503. [DOI:10.3389/fnins.2019.00503] [PMID] [PMCID]

25. [25] Gintzler AR, Liu NH. The maternal spinal cord: biochemical and physiological correlates of steroid-activated antinociceptive processes. Prog Brain Res 2001; 133: 83-97. [DOI:10.1016/S0079-6123(01)33007-8]

26. [26] De Nicola AF, Labombarda F, Deniselle MC, Gonzalez SL, Garay L, Meyer M, et al. Progesterone neuroprotection in traumatic CNS injury and motoneuron degeneration. Front Neuroendocrin 2009; 30: 173-187. [DOI:10.1016/j.yfrne.2009.03.001] [PMID]

27. [27] Theis V, Theiss C. Progesterone effects in the nervous system. Anat Rec (Hoboken) 2019; 302: 1276-1286. [DOI:10.1002/ar.24121] [PMID]

28. [28] De Nicola AF, Deniselle G, Garay L, Meyer M, Gargiulo‐Monachelli G, Guennoun R, et al. Progesterone protective effects in neurodegeneration and neuroinflammation. J Neuroendocrinol 2013; 25: 1095-1103. [DOI:10.1111/jne.12043] [PMID]

29. [29] Koenig HL, Schumacher M, Ferzaz B, Thi AN, Ressouches A, Guennoun R, et al. Progesterone synthesis and myelin formation by Schwann cells. Science 1995; 268: 1500-1503. [DOI:10.1126/science.7770777] [PMID]

30. [30] Leonelli E, Bianchi R, Cavaletti G, Caruso D, Crippa D, Garcia-Segura L, et al. Progesterone and its derivatives are neuroprotective agents in experimental diabetic neuropathy: a multimodal analysis. Neuroscience 2007; 144: 1293-1304. [DOI:10.1016/j.neuroscience.2006.11.014] [PMID]

31. [31] Mensah-Nyagan AG, Do-Rego JL, Beaujean D, Pelletier G, Vaudry H. Neurosteroids: expression of steroidogenic enzymes and regulation of steroid biosynthesis in the central nervous system. Pharmacol Rev 1999; 51: 63-82.

32. [32] Melcangi RC, Garcia-Segura LM. Therapeutic approaches to peripheral neuropathy based on neuroactive steroids. Expert Rev Neurother 2006; 6: 1121-1125. [DOI:10.1586/14737175.6.8.1121] [PMID]

33. [33] Lambert JJ, Cooper MA, Simmons RD, Weir CJ, Belelli D. Neurosteroids: endogenous allosteric modulators of GABAA receptors. Psychoneuroendocrinol 2009; 34: S48-S58. [DOI:10.1016/j.psyneuen.2009.08.009] [PMID]

34. [34] Kaur P, Jodhka PK, Underwood WA, Bowles CA, de Fiebre NC, de Fiebre CM, Singh M. Progesterone increases brain‐derived neuroptrophic factor expression and protects against glutamate toxicity in a mitogen‐activated protein kinase‐and phosphoinositide‐3 kinase‐dependent manner in cerebral cortical explants. J Neurosci Res 2007; 85: 2441-2449. [DOI:10.1002/jnr.21370] [PMID] [PMCID]

35. [35] Goodchild C, Guo Z, Nadeson R. Antinociceptive properties of neurosteroids I.: Spinally-mediated antinociceptive effects of water-soluble aminosteroids. Pain 2000; 88: 23-29. [DOI:10.1016/S0304-3959(00)00301-8]

36. [36] Labombarda F, Meffre D, Delespierre B, Krivokapic-Blondiaux S, Chastre A, Thomas P, et al. Membrane progesterone receptors localization in the mouse spinal cord. Neuroscience 2010; 166: 94-106. [DOI:10.1016/j.neuroscience.2009.12.012] [PMID]

37. [37] Onodera Y, Kanao-Kanda M, Kanda H, Sasakawa T, Iwasaki H, Kunisawa T. Pregnancy suppresses neuropathic pain induced by chronic constriction injury in rats through the inhibition of TNF-alpha. J Pain Res 2017; 10: 567-574. [DOI:10.2147/JPR.S121810] [PMID] [PMCID]

38. [38] Chen YW, Chen SH, Chou W, Lo YM, Hung CH, Lin M-T. Exercise pretraining protects against heatstroke-induced cerebral ischemia in rats. Br J Sports Med 2007; 41: 597-602. [DOI:10.1136/bjsm.2006.033829] [PMID] [PMCID]

39. [39] Cobianchi S, Casals-Diaz L, Jaramillo J, Navarro X. Differential effects of activity dependent treatments on axonal regeneration and neuropathic pain after peripheral nerve injury. Exper Neurol 2013; 240: 157-167. [DOI:10.1016/j.expneurol.2012.11.023] [PMID]

40. [40] Chen CC, Chang CP. How to modify the forced running wheel for ischemic stroke rehabilitation in rats. Neuropsychiatry (London) 2018; 8: 1061-1072.

41. [41] Chen YW, Li YT, Chen YC, Li ZY, Hung CH. Exercise training attenuates neuropathic pain and cytokine expression after chronic constriction injury of rat sciatic nerve. Anesth Anal 2012; 114: 1330-1337. [DOI:10.1213/ANE.0b013e31824c4ed4] [PMID]

42. [42] Ghanbari A, Asgari A, Kaka G, Falahatpishe H, Naderi A, Jorjani M. In vivo microdialysis of glutamate in ventroposterolateral nucleus of thalamus following electrolytic lesion of spinothalamic tract in rats. Exper Brain Res 2014; 232: 415-421. [DOI:10.1007/s00221-013-3749-0] [PMID]

43. [43] Detloff MR, Smith EJ, Molina DQ, Ganzer PD, Houlé JD. Acute exercise prevents the development of neuropathic pain and the sprouting of non-peptidergic (GDNF-and artemin-responsive) c-fibers after spinal cord injury. Exp Neurol 2014; 255: 38-48. [DOI:10.1016/j.expneurol.2014.02.013] [PMID] [PMCID]

44. [44] Sluka KA, O'Donnell JM, Danielson J, Rasmussen LA. Regular physical activity prevents development of chronic pain and activation of central neurons. J Appl Physiol 2012; 114: 725-733. [DOI:10.1152/japplphysiol.01317.2012] [PMID] [PMCID]

45. [45] Pitcher MH. The impact of exercise in rodent models of chronic pain. Curr Osteoporos Rep 2018; 16: 344-359. [DOI:10.1007/s11914-018-0461-9] [PMID] [PMCID]

46. [46] Abdelhamid RE, Kovacs KJ, Pasley JD, Nunez MG, Larson AA. Forced swim-induced musculoskeletal hyperalgesia is mediated by CRF2 receptors but not by TRPV1 receptors. Neuropharmacology 2013; 72: 29-37. [DOI:10.1016/j.neuropharm.2013.04.016] [PMID] [PMCID]